Skeletal Muscle Function

Clinical Biochemistry of Domestic Animals, Sixth Edition

Volumn , Issue , 2008, Pages 459-484

  Valberg, Stephanie J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882295486     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-370491-7.00015-5     Document Type: Chapter

References (201)

1. P.J. Adhihetty, I. Irrcher, A.M. Joseph, V. Ljubicic and D.A. Hood (2003) Plasticity of skeletal muscle mitochondria in response to contractile activity. Exp. Physiol. 88 99-107.
2. M. Aleman, J. Riehl, B.M. Aldridge, R.A. Lecouteur, J.L. Stott and I.N. Pessah (2004) Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia. Muscle Nerve 30 356-365.
3. M. Aleman, J.L. Watson, D.C. Williams, R.A. Lecouteur, J.E. Nieto and G.D. Shelton (2006) Myopathy in horses with pituitary pars intermedia dysfunction (Cushing's disease). Neuromuscul. Disord
4. M.G. Anderson (1975) The influence of exercise on serum enzyme levels in the horse. Equine Vet. J. 7 160-165.
5. S. Angelos, S.J. Valberg, B.P. Smith, P.S. McQuarrie, S. Shanske, S. Tsujino, S. DiMauro and G.H. Cardinet III. (1995) Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in 6 related Char olais cattle. Muscle Nerve 18 736-740.
6. E.J. Annandale, S.J. Valberg and B. Essen-Gustavsson (2005) Effects of submaximal exercise on adenine nucleotide concentrations in skeletal muscle fibers of horses with polysaccharide storage myopathy. Am. J. Vet. Res. 66 839-845.
7. E.J. Annandale, S.J. Valberg, J.R. Mickelson and E.R. Seaquist (2004) Insulin sensitivity and skeletal muscle glucose transport in horses with equine polysaccharide storage myopathy. Neuromuscul. Disord. 14 666-674.
8. S.A. Argiroudis, J.E. Kent and D.J. Blackmore (1982) Observations on the isoenzymes of creatine kinase in equine serum and tissues. Equine Vet. J. 14 317-321.
9. K.M. Baldwin, W.W. Winder, R.L. Terjung and J.O. Holloszy (1973) Glycolytic enzymes in different types of skeletal muscle: adaptation to exercise. Am. J. Physiol. 225 962-966.
10. M. Barany (1967) ATPase activity of myosin correlated with speed of muscle shortening. J. Gen. Physiol. 50(suppl 218), 197-218.
11. J.A. Barden and P. Mason (1978) Muscle crossbridge stroke and activity revealed by optical diffraction. Science 199 1212-1213.
12. P. Bennard, P. Imbeault and E. Doucet (2005) Maximizing acute fat utilization: effects of exercise, food, and individual characteristics. Can. J. Appl. Physiol. 30 475-499.
13. D.P. Bhalerao, Y. Rajpurohit, C.H. Vite and U. Giger (2002) Detection of a genetic mutation for myotonia congenita among miniature schnauzers and identification of a common carrier ancestor. Am. J. Vet. Res. 63 1443-1447.
14. J.A. Bilstrom, S.J. Valberg, D. Bernoco and J.R. Mickelson (1998) Genetic test for myophosphorylase deficiency in Charolais cattle. Am. J. Vet. Res. 59 267-270.
15. D.J. Blackmore and D. Elton (1975) Enzyme activity in the serum of thoroughbred horses in the United Kingdom. Equine Vet. J. 7 34-39.
16. K.G. Braund, A.R. Dillon, J.R. August and V.K. Ganjam (1981) Hypothyroid myopathy in two dogs. Vet. Pathol. 18 589-598.
17. K.G. Braund, A.R. Dillon and R.L. Mikeal (1980) Experimental investigation of glucocorticoid-induced myopathy in the dog. Exp. Neurol. 68 50-71.
18. K.G. Braund, A.R. Dillon, R.L. Mikeal and J.R. August (1980) Subclinical myopathy associated with hyperadrenocorticism in the dog. Vet. Pathol. 17 134-148.
19. K.G. Braund, E.J. Hoff and E.Y. Richardson (1978) Histochemical identification of fiber types in canine skeletal muscle. Am. J. Vet. Res. 39 561-565.
20. E.B. Breitschwerdt, J.N. Kornegay, S.J. Wheeler, J.B. Stevens and C.J. Baty (1992) Episodic weakness associated with exertional lactic acidosis and myopathy in Old English sheepdog littermates. J. Am. Vet. Med. Assoc. 201 731-736.
21. M.H. Brooke and K.K. Kaiser (1970) Muscle fiber types: how many and what kind? Arch. Neurol. 23 369-379.
22. S.H. Bryant and D. Conte-Camerino (1991) Chloride channel regulation in the skeletal muscle of normal and myotonic goats. Pflugers Arch. 417 605-610.
23. J.A. Bulcke and A.L. Sherwin (1969) Organ specificity of creatine phosphokinase muscle isoenzyme. Immunochemistry 6 681-687.
24. I.A. Burgener, A. Kovacevic, G.N. Mauldin and C.W. Lombard (2006) Cardiac troponins as indicators of acute myocardial damage in dogs. J. Vet. Intern. Med. 20 277-283.
25. R.E. Burke (1975) Motor unit properties and selective involvement in movement. Exerc. Sport Sci. Rev. 3 31-81.
26. S.C. Cannon, L.J. Hayward, J. Beech and R.H. Brown Jr. (1995) Sodium channel inactivation is impaired in equine hyperkalemic periodic paralysis. J. Neurophysiol. 73 1892-1899.
27. G.H. Cardinet III. and T.A. Holliday (1979) Neuromuscular diseases of domestic animals: a summary of muscle biopsies from 159 cases. Ann. NY Acad. Sci. 317 290-313.
28. G.H. Cardinet III., M.E. Fowler and W.S. Tyler (1963) The effects of training, exercise, and tying-up on serum transaminase activities in the horse. Am. J. Vet. Res. 24 980-984.
29. G.H. Cardinet, J.F. Littrell and R.A. Freedland (1967) Comparative investigations of serum creatine phosphokinase and glutamic-oxaloacetic transaminase activities in equine paralytic myoglobinuria. Res. Vet. Sci. 8 219-226.
30. D. Carling (2004) The AMP-activated protein kinase cascade: a unifying system for energy control. Trends Biochem. Sci. 29 18-24.
31. L. Ceh, J.G. Hauge, R. Svenkerud and A. Strande (1976) Glycogenosis type III in the dog. Acta Vet. Scand. 17 210-222.
32. C.E. Cornelius, J. Bishop, J. Switzer and E.A. Rhode (1959) Serum and tissue transaminase activities in domestic animals. Cornell Vet. 49 116-126.
33. C.E. Cornelius, L.G. Burnham and H.E. Hill (1963) Serum transaminase activities of thoroughbred horses in training. J. Am. Vet. Med. Assoc. 142 639-642.
34. R.W. Craig and R. Padron (2004) Molecular structure of the sarcomere. A.G. Engel, C. Franzini-Armstrong (Eds) Myology: Basic and Clinical New York: McGraw-Hill 129-166.
35. C.M. Cutmore, D.H. Snow and E.A. Newsholme (1986) Effects of training on enzyme activities involved in purine nucleotide metabolism in Thoroughbred horses. Equine Vet. J. 18 72-73.
36. B.M. Davis, M.E. McCurrach, K.L. Taneja, R.H. Singer and D.E. Housman (1997) Expansion of a CUG trinucleotide repeat in the 39 untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. USA 94 7388-7393.
37. D.M. Dawson, H.M. Eppenberger and M.E. Eppenberger (1968) Multiple molecular forms of creatine kinases. Ann. NY Acad. Sci. 151 616-626.
38. D.M. Dawson and I.H. Fine (1967) Creatine kinase in human tissues. Arch. Neurol. 16 175-180.
39. D.M. Dawson and F.C. Romanul (1964) Enzymes in muscles. II. Histochemical and quantitative studies. Arch. Neurol. 11 369-378.
40. F.D. De La Corte, S.J. Valberg, J.M. MacLeay, S.E. Williamson and J.R. Mickelson (1999) Glucose uptake in horses with polysaccharide storage myopathy. Am. J. Vet. Res. 60 458-462.
41. J.A. Dennis, C. Moran and P.J. Healy (2000) The bovine alpha-glucosidase gene: coding region, genomic structure, and mutations that cause bovine generalized glycogenosis. Mamm. Genome 11 206-212.
42. C.W. Dewey, C.S. Bailey, G.D. Shelton, P.H. Kass and G.H. Cardinet III. (1997) Clinical forms of acquired myasthenia gravis in dogs: 25 cases (1988–1995). J. Vet. Intern. Med. 11 50-57.
43. P.J. Dickinson, B.K. Sturges, G.D. Shelton and R.A. Lecouteur (2005) Congenital myasthenia gravis in smooth-haired miniature dachshund dogs. J. Vet. Intern. Med. 19 920-923.
44. S. DiMauro and E. Bonilla (2004) Mitochondrial encephalomyopathies. A.G. Engel, C. Franzini-Armstrong (Eds) Myology: Basic and Clinical New York: McGraw-Hill 1623-1662.
45. S. DiMauro, S. Tsujino, S. Shanske and L.P. Rowland (1995) Biochemistry and molecular genetics of human glycogenoses: an overview. Muscle Nerve 3 S10-sS17.
46. P.R. Dorling, J.M. Howell and J.M. Gawthorne (1981) Skeletal-muscle alpha-glucosidases in bovine generalized glycogenosis type II. Biochem. J. 198 409-412.
47. V. Dubowitz and M.H. Brooke (1973) Muscle Biopsy: A Modern Approach. Philadelphia: Saunders pp. 1-471
48. I.D. Duncan, I.R. Griffiths and A.S. Nash (1977) Myotonia in canine Cushing's disease. Vet. Rec. 100 30-31.
49. J.C. Eccles, R.M. Eccles and A. Lundberg (1958) The action potentials of the alpha motoneurones supplying fast and slow muscles. J. Physiol. 142 275-291.
50. E. Eisenberg, L. Dobkin and W.W. Kielley (1972) Binding of actin to heavy meromyosin in the absence of adenosine triphosphate. Biochemistry 11 4657-4660.
51. A. Engel and C. Franzini-Armstrong (2004) Myology: Basic and Clinical. New York: McGraw-Hill
52. A.G. Engel (2004) Neuromuscular junction. A.G. Engel, C. Franzini-Armstrong (Eds) Myology: Basic and Clinical New York: McGraw-Hill 325-373.
53. A.G. Engel and R. Hohfield (2004) Acquired autoimmune myasthenia gravis. A.G. Engel, C. Franzini-Armstrong (Eds) Myology: Basic and Clinical New York: McGraw-Hill 1755-1790.
54. A.G. Engel, K. Ohno and S. Sine (2004) Congenital myasthenia gravis. A.G. Engel, C. Franzini-Armstrong (Eds) Myology: Basic and Clinical New York: McGraw-Hill 1801-1844.
55. H.M. Eppenberger, M. Eppenberger, R. Richterich and H. Aebi (1964) The ontogeny of creatine kinase isozymes. Dev. Biol. 10 1-16.
56. B. Essen-Gustavsson, N. Roneus and A.R. Poso (1997) Metabolic response in skeletal muscle fibres of standardbred trotters after racing. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 117 431-436.
57. D. Eto, S. Yamano, Y. Kasashima, T. Sugiura, T. Nasu, M. Tokuriki and H. Miyata (2003) Effect of controlled exercise on middle gluteal muscle fibre composition in thoroughbred foals. Equine Vet. J. 35 676-680.
58. D. Eto, S. Yamano, K. Mukai, T. Sugiura, T. Nasu, M. Tokuriki and H. Miyata (2004) Effect of high intensity training on anaerobic capacity of middle gluteal muscle in thoroughbred horses. Res. Vet. Sci. 76 139-144.
59. J. Evans, D. Levesque and G.D. Shelton (2004) Canine inflammatory myopathies: a clinicopathologic review of 200 cases. J. Vet. Intern. Med. 18 679-691.
60. J.W. Fiolet, A.F. Willebrands, K.I. Lie and H.F. ter Welle (1977) Determination of creatine kinase isoenzyme MB (CK-MB): comparison of methods and clinical evaluation. Clin. Chim. Acta 80 23-35.
61. A.M. Firshman, J.D. Baird and S.J. Valberg (2005) Prevalences and clinical signs of polysaccharide storage myopathy and shivers in Belgian draft horses. J. Am. Vet. Med. Assoc. 227 1958-1964.
62. C. Franzini-Armstrong and A.R. Horowitz (2004) The cytoskeleton: maintenance of muscle fiber integrity. A.G. Engel, C. Franzini-Armstrong (Eds) Myology: Basic and Clinical New York: McGraw-Hill 443-454.
63. S. Fuchs, R. Kornowski, R. Mehran, L.F. Satler, A.D. Pichard, K.M. Kent, M.K. Hong, S. Slack, G.W. Stone and M.B. Leon (1999) Cardiac troponin I levels and clinical outcomes in patients with acute coronary syndromes: the potential role of early percutaneous revascularization. J. Am. Coll. Cardiol. 34 1704-1710.
64. J. Fujii, K. Otsu, F. Zorzato, L.S. De, V.K. Khanna, J.E. Weiler, P.J. O'Brien and D.H. Maclennan (1991) Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 253 448-451.
65. J.C. Fyfe (1995) Glycogen storage disease in cats. J. Am. Vet. Med. Assoc. 206 286.
66. J.C. Fyfe, U. Giger, T.J. Van Winkle, M.E. Haskins, S.A. Steinberg, P. Wang and D.F. Patterson (1992) Glycogen storage disease type IV: inherited deficiency of branching enzyme activity in cats. Pediatr. Res. 32 719-725.
67. U. Giger, Z. Argov, M. Schnall, W.J. Bank and B. Chance (1988) Metabolic myopathy in canine muscle-type phosphofructokinase deficiency. Muscle Nerve 11 1260-1265.
68. U. Giger, J.W. Harvey, R.A. Yamaguchi, P.K. McNulty, A. Chiapella and E. Beutler (1985) Inherited phosphofructokinase deficiency in dogs with hyperventilation-induced hemolysis: increased in vitro and in vivo alkaline fragility of erythrocytes. Blood 65 345-351.
69. U. Giger, A.M. Kelly and P.S. Teno (1988) Biochemical studies of canine muscle phosphofructokinase deficiency. Enzyme 40 25-29.
70. U. Giger, M.P. Reilly, T. Asakura, C.J. Baldwin and J.W. Harvey (1986) Autosomal recessive inherited phosphofructokinase deficiency in English springer spaniel dogs. Anim. Genet. 17 15-23.
71. L.C. Golland, D.L. Evans, C.M. McGowan, D.R. Hodgson and R.J. Rose (2003) The effects of overtraining on blood volumes in standardbred racehorses. Vet. J. 165 228-233.
72. P.D. Gollnick, R.B. Armstrong, C.W. Saubert, K. Piehl and B. Saltin (1972) Enzyme activity and fiber composition in skeletal muscle of untrained and trained men. J. Appl. Physiol. 33 312-319.
73. L. Gorza (1990) Identification of a novel type 2 fiber population in mammalian skeletal muscle by combined use of histochemical myosin ATPase and anti-myosin monoclonal antibodies. J. Histochem. Cytochem. 38 257-265.
74. G.H. Graziotti, C.M. Rios and J.L. Rivero (2001) Evidence for three fast myosin heavy chain isoforms in type II skeletal muscle fibers in the adult llama (Lama glama). J. Histochem. Cytochem. 49 1033-1044.
75. G.E. Griffin, P.E. Williams and G. Goldspink (1971) Region of longitudinal growth in striated muscle fibres. Nat. New Biol. 232 28-29.
76. L.A. Grobler, M. Collins, M.I. Lambert, C. Sinclair-Smith, W. Derman, G.A. St Clair and T.D. Noakes (2004) Skeletal muscle pathology in endurance athletes with acquired training intolerance. Br. J. Sports Med. 38 697-703.
77. A. Hamdan, N. Zafrir, A. Sagie and R. Kornowski (2006) Modalities to assess myocardial viability in the modern cardiology era. Coron. Artery Dis. 17 567-576.
78. D.G. Hardie (2004) AMP-activated protein kinase: a key system mediating metabolic responses to exercise. Med. Sci. Sports Exerc. 36 28-34.
79. P.S. Harper and D.G. Monckton (2004) Myotonic dystrophy. A.G. Engel, C. Franzini-Armstrong (Eds) Myology: Basic and Clinical New York: McGraw-Hill 1039-1076.
80. R.C. Harris, D.J. Marlin, D.H. Snow and R.A. Harkness (1991) Muscle ATP loss and lactate accumulation at different work intensities in the exercising Thoroughbred horse. Eur. J. Appl. Physiol. Occup. Physiol. 62 235-244.
81. J.W. Harvey, M.B. Calderwood Mays, K.E. Gropp and F.J. Denaro (1990) Polysaccharide storage myopathy in canine phosphofructokinase deficiency (type VII glycogen storage disease). Vet. Pathol. 27 1-8.
82. J.W. Harvey and G.R. Reddy (1989) Postnatal hematologic development in phosphofructokinase-deficient dogs. Blood 74 2556-2561.
83. R.J. Havel, L.G. Ekelund and A. Holmgren (1967) Kinetic analysis of the oxidation of palmitate-1-14C in man during prolonged heavy muscular exercise. J. Lipid Res. 8 366-373.
84. J.J. Heffron, L. Bomzon and R.A. Pattinson (1976) Observations on plasma creatine phosphokinase activity in dogs. Vet. Rec. 98 338-340.
85. G.A. Hegreberg and S.M. Reed (1990) Skeletal muscle changes associated with equine myotonic dystrophy. Acta Neuropathol. (Berl.) 80 426-431.
86. R. Heine, A.L. George Jr., U. Pika, F. Deymeer, R. Rudel and F. Lehmann-Horn (1994) Proof of a non-functional muscle chloride channel in recessive myotonia congenita (Becker) by detection of a 4 base pair deletion. Hum. Mol. Genet. 3 1123-1128.
87. P. Henckel (1983) Training and growth induced changes in the middle gluteal muscle of young Standardbred trotters. Equine Vet. J. 15 134-140.
88. D.R. Hodgson (1985) Muscular adaptations to exercise and training. Vet. Clin. North Am. Equine Pract. 1 533-548.
89. E.P. Hoffman, R.H. Brown Jr. and L.M. Kunkel (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51 919-928.
90. J.F. Hoh and S. Hughes (1988) Myogenic and neurogenic regulation of myosin gene expression in cat jaw-closing muscles regenerating in fast and slow limb muscle beds. J. Muscle Res. Cell Motil. 9 59-72.
91. J.O. Holloszy (1982) Muscle metabolism during exercise. Arch. Phys. Med. Rehabil. 63 231-234.
92. O. Holloszy (1982) Enzymatic adaptations of skeletal muscle to endurance exercise. Curr. Probl. Clin. Biochem. 11 118-121.
93. N. Holmgren and S. Valberg (1992) Measurement of serum myoglobin concentrations in horses by immunodiffusion. Am. J. Vet. Res. 53 957-960.
94. J.E. Houlton and M.E. Herrtage (1980) Mitochondrial myopathy in the Sussex spaniel. Vet. Rec. 106 206.
95. J.M. Howell, P.R. Dorling, R.D. Cook, W.F. Robinson, S. Bradley and J.M. Gawthorne (1981) Infantile and late onset form of generalised glycogenosis type II in cattle. J. Pathol. 134 267-277.
96. B.F. Hurley, P.M. Nemeth, W.H. Martin III., J.M. Hagberg, G.P. Dalsky and J.O. Holloszy (1986) Muscle triglyceride utilization during exercise: effect of training. J. Appl. Physiol. 60 562-567.
97. H.E. Huxley, R.M. Simmons, A.R. Faruqi, M. Kress, J. Bordas and M.H. Koch (1983) Changes in the X-ray reflections from contracting muscle during rapid mechanical transients and their structural implications. J. Mol. Biol. 169 469-506.
98. B. Kiens (2006) Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol. Rev. 86 205-243.
99. J.N. Kornegay, S.M. Tuler, D.M. Miller and D.C. Levesque (1988) Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve 11 1056-1064.
100. S. Labeit, B. Kolmerer and W.A. Linke (1997) The giant protein titin: emerging roles in physiology and pathophysiology. Circ. Res. 80 290-294.
101. A. Lagace, D.S. Bell, A.L. Moxon and W.D. Pounden (1961) Serum transaminase in the blood of lambs given preventive treatments for white muscle disease. Am. J. Vet. Res. 22 686-688.
102. F. Lehmann-Horn, K. Jurkat-Rott and R. Rudel (2002) Periodic paralysis: understanding channelopathies. Curr. Neurol. Neurosci. Rep. 2 61-69.
103. S.F. Li, J. Zapata and E. Tillem (2005) The prevalence of false-positive cardiac troponin I in ED patients with rhabdomyolysis. Am. J. Emerg. Med. 23 860-863.
104. X. Li, S.M. Hughes, G. Salviati, A. Teresi and L. Larsson (1996) Thyroid hormone effects on contractility and myosin composition of soleus muscle and single fibres from young and old rats. J. Physiol. 494(pt. 2), 555-567.
105. X. Li and L. Larsson (1997) Contractility and myosin isoform compositions of skeletal muscles and muscle cells from rats treated with thyroid hormone for 0, 4 and 8 weeks. J. Muscle Res. Cell Motil. 18 335-344.
106. A. Lindholm, H. Bjerneld and B. Saltin (1974) Glycogen depletion pattern in muscle fibres of trotting horses. Acta Physiol. Scand. 90 475-484.
107. M.I. Lindinger, J.M. Kowalchuk and G.J. Heigenhauser (2005) Applying physicochemical principles to skeletal muscle acid-base status. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289 R891-rR894.
108. L. Linnane, A.L. Serrano and J.L. Rivero (1999) Distribution of fast myosin heavy chain-based muscle fibres in the gluteus medius of untrained horses: mismatch between antigenic and ATPase determinants. J. Anat. 194(pt. 3), 363-372.
109. C.L. Liquori, K. Ricker, M.L. Moseley, J.F. Jacobsen, W. Kress, S.L. Naylor, J.W. Day and L.P. Ranum (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293 864-867.
110. W.F. Loeb, L.A. Nagode and W.J. Frajola (1966) The distribution of four enzymes between canine serum and erythrocytes. Enzymol. Biol. Clin. (Basel) 7 215-224.
111. J.M. Lowenstein (1972) Ammonia production in muscle and other tissues: the purine nucleotide cycle. Physiol. Rev. 52 382-414.
112. S. Lowey, H.S. Slayter, A.G. Weeds and H. Baker (1969) Substructure of the myosin molecule. I. Subfragments of myosin by enzymic degradation. J. Mol. Biol. 42 1-29.
113. R.W. Lymn and E.W. Taylor (1971) Mechanism of adenosine triphosphate hydrolysis by actomyosin. Biochemistry 10 4617-4624.
114. A.L. Magleby (2004) Neuromuscular transmission. A.G. Engel, C. Franzini-Armstrong (Eds) Myology: Basic and Clinical New York: McGraw-Hill 373-396.
115. A.N. Martonosi and S. Pikula (2003) The network of calcium regulation in muscle. Acta Biochim. Pol. 50 1-30.
116. K. Maruyama (1999) Comparative aspects of muscle elastic proteins. Rev. Physiol. Biochem. Pharmacol. 138 1-18.
117. M.E. McCue, S.J. Valberg, M.B. Miller, C. Wade, S. DiMauro, H.O. Akman and J.R. Mickelson (2008) Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenesis. Genomics 91 458-466.
118. J.R. Mickelson and C.F. Louis (1996) Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects. Physiol. Rev. 76 537-592.
119. N.S. Moise, B.A. Valentine, C.A. Brown, H.N. Erb, K.A. Beck, B.J. Cooper and R.F. Gilmour (1991) Duchenne's cardiomyopathy in a canine model: electrocardiographic and echocardiographic studies. J. Am. Coll. Cardiol. 17 812-820.
120. P.A. Mole, K.M. Baldwin, R.L. Terjung and J.O. Holloszy (1973) Enzymatic pathways of pyruvate metabolism in skeletal muscle: adaptations to exercise. Am. J. Physiol. 224 50-54.
121. N. Monnier, G. Kozak-Ribbens, R. Krivosic-Horber, Y. Nivoche, D. Qi, N. Kraev, J. Loke, P. Sharma, V. Tegazzin, D. Figarella-Branger, N. Romero, P. Mezin, D. Bendahan, J.F. Payen, T. Depret, D.H. Maclennan and J. Lunardi (2005) Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility. Hum. Mutat. 26 413-425.
122. P. Montagna, R. Liguori, L. Monari, P.N. Strong, R. Riva, S.V. Di, G. Gandini and M. Cipone (2001) Equine muscular dystrophy with myotonia. Clin. Neurophysiol. 112 294-299.
123. T. Murakami, I. Saito and K. Mochizuki (1980) Glycogen in the specialized cardiac muscle of the quail. Nippon Juigaku. Zasshi 42 99-101.
124. J.M. Naylor (1997) Hyperkalemic periodic paralysis. Vet. Clin. North Am. Equine Pract. 13 129-144.
125. T.E. Nelson (1991) Malignant hyperthermia in dogs. J. Am. Vet. Med. Assoc. 198 989-994.
126. T. Nishita, T. Ohohashi and M. Asari (1995) Determination of carbonic anhydrase III isoenzyme concentration in sera of racehorses with exertional rhabdomyolysis. Am. J. Vet. Res. 56 162-166.
127. T.D. Noakes, G.A. St Clair and E.V. Lambert (2004) From catastrophe to complexity: a novel model of integrative central neural regulation of effort and fatigue during exercise in humans. Br. J. Sports Med. 38 511-514.
128. S. Numa, T. Tanabe, H. Takeshima, A. Mikami, T. Niidome, S. Nishimura, B.A. Adams and K.G. Beam (1990) Molecular insights into excitation-contraction coupling. Cold Spring Harb. Symp. Quant. Biol. 55 1-7.
129. J.S. Orvis and G.H. Cardinet III. (1981) Canine muscle fiber types and susceptibility of masticatory muscles to myositis. Muscle Nerve 4 354-359.
130. T. Otani and H. Mochizuki (1977) [Glycogen storage disease (III ?) of dogs]. Jikken Dobutsu 26 172-173.
131. O. Paciello, P. Maiolino, G. Fatone and S. Papparella (2003) Mitochondrial myopathy in a german shepherd dog. Vet. Pathol. 40 507-511.
132. A.C. Palmer (1977) Myasthenia gravis in the dog. Vet. Rec. 101 313.
133. C.M. Pflugfelder, G.H. Cardinet III., H. Lutz, T.A. Holliday and R.J. Hansen (1981) Acquired canine myasthenia gravis: immunocytochemical localization of immune complexes at neuromuscular junctions. Muscle Nerve 4 289-295.
134. S.R. Platt, C.L. Chrisman and G.D. Shelton (1999) Lipid storage myopathy in a cocker spaniel. J. Small Anim. Pract. 40 31-34.
135. M. Rafiquzzaman, R. Svenkerud, A. Strande and J.G. Hauge (1976) Glycogenosis in the dog. Acta Vet. Scand. 17 196-209.
136. S.M. Reed, G.A. Hegreberg, W.M. Bayly, C.M. Brown, M.R. Paradis and R.M. Clemmons (1988) Progressive myotonia in foals resembling human dystrophia myotonica. Muscle Nerve 11 291-296.
137. J.A. Render, R.S. Common, F.A. Kennedy, M.Z. Jones and J.C. Fyfe (1999) Amylopectinosis in fetal and neonatal quarter horses. Vet. Pathol. 36 157-160.
138. M.J. Rennie, J. Bohe, K. Smith, H. Wackerhage and P. Greenhaff (2006) Branched-chain amino acids as fuels and anabolic signals in human muscle. J. Nutr. 136(suppl. 1), 264S-s268S.
139. A.J. Reuser, M.A. Kroos, M.M. Hermans, A.G. Bijvoet, M.P. Verbeet, O.P. van Diggelen, W.J. Kleijer and A.T. Van der Ploeg (1995) Glycogenosis type II (acid maltase deficiency). Muscle Nerve 3 S61-sS69.
140. T.H. Rhodes, C.H. Vite, U. Giger, D.F. Patterson, C. Fahlke and A.L. George Jr. (1999) A missense mutation in canine C1C-1 causes recessive myotonia congenita in the dog. FEBS Lett. 456 54-58.
141. J.L. Rivero, A.L. Serrano, P. Henckel and E. Aguera (1993) Muscle fiber type composition and fiber size in successfully and unsuccessfully endurance-raced horses. J. Appl. Physiol. 75 1758-1766.
142. R.A. Robergs, F. Ghiasvand and D. Parker (2004) Biochemistry of exercise-induced metabolic acidosis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 R502-rR516.
143. M.C. Roberts, J.R. Mickelson, E.E. Patterson, T.E. Nelson, P.J. Armstrong, D.B. Brunson and K. Hogan (2001) Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Anesthesiology 95 716-725.
144. J.D. Roussel and O.T. Stallcup (1966) Influence of age and season on phosphatase and transaminase activities in blood serum of bulls. Am. J. Vet. Res. 27 1527-1530.
145. N.A. Rubenstein and A.M. Kelly (2004) The diversity of muscle fiber types and its origin during development. A.G. Engel, C. Franzini-Armstrong (Eds) Myology: Basic and Clinical New York: McGraw-Hill 87-103.
146. J.A. Rudolph, S.J. Spier, G. Byrns, C.V. Rojas, D. Bernoco and E.P. Hoffman (1992) Periodic paralysis in quarter horses: a sodium channel mutation disseminated by selective breeding. Nat. Genet. 2 144-147.
147. S.D. Russell, N. Cambon, B. Nadal-Ginard and R.G. Whalen (1988) Thyroid hormone induces a nerve-independent precocious expression of fast myosin heavy chain mRNA in rat hindlimb skeletal muscle. J. Biol. Chem. 263 6370-6374.
148. K. Sahlin (1986) Muscle fatigue and lactic acid accumulation. Acta Physiol. Scand. Suppl. 556 83-91.
149. K. Sahlin, L. Edstrom, H. Sjoholm and E. Hultman (1981) Effects of lactic acid accumulation and ATP decrease on muscle tension and relaxation. Am. J. Physiol. 240 C121-cC126.
150. B. Saltin, J. Henriksson, E. Nygaard, P. Andersen and E. Jansson (1977) Fiber types and metabolic potentials of skeletal muscles in sedentary man and endurance runners. Ann. NY Acad. Sci. 301 3-29.
151. S.J. Schatzberg and G.D. Shelton (2004) Newly identified neuromuscular disorders. Vet. Clin. North Am. Small Anim. Pract. 34 1497-1524.
152. J.C. Seidel (1967) Studies on myosin from red and white skeletal muscles of the rabbit. II. Inactivation of myosin from red muscles under mild alkaline conditions. J. Biol. Chem. 242 5623-5629.
153. A.L. Serrano, E. Quiroz-Rothe and J.L. Rivero (2000) Early and long-term changes of equine skeletal muscle in response to endurance training and detraining. Pflugers Arch. 441 263-274.
154. N.J. Sharp, J.N. Kornegay, S.D. Van Camp, M.H. Herbstreith, S.L. Secore, S. Kettle, W.Y. Hung, C.D. Constantinou, M.J. Dykstra, A.D. Roses and R.J. Bartlett (1992) An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 13 115-121.
155. G.D. Shelton (1999) Acquired myasthenia gravis: what we have learned from experimental and spontaneous animal models. Vet. Immunol. Immunopathol. 69 239-249.
156. G.D. Shelton (2002) Myasthenia gravis and disorders of neuromuscular transmission. Vet. Clin. North Am. Small Anim. Pract. 32 189-206. vii.
157. G.D. Shelton (2004) Muscular dystrophies: expanding our knowledge in companion animals. Vet. J. 168 6-8.
158. G.D. Shelton and G.H. Cardinet III. (1987) Pathophysiologic basis of canine muscle disorders. J. Vet. Intern. Med. 1 36-44.
159. G.D. Shelton, G.H. Cardinet III. and E. Bandman (1987) Canine masticatory muscle disorders: a study of 29 cases. Muscle Nerve 10 753-766.
160. G.D. Shelton, G.H. Cardinet III., E. Bandman and P. Cuddon (1985) Fiber type-specific autoantibodies in a dog with eosinophilic myositis. Muscle Nerve 8 783-790.
161. G.D. Shelton, G.H. Cardinet and J.M. Lindstrom (1988) Canine and human myasthenia gravis autoantibodies recognize similar regions on the acetylcholine receptor. Neurology 38 1417-1423.
162. G.D. Shelton and E. Engvall (2002) Muscular dystrophies and other inherited myopathies. Vet. Clin. North Am. Small Anim. Pract. 32 103-124.
163. G.D. Shelton and E. Engvall (2005) Canine and feline models of human inherited muscle diseases. Neuromuscul. Disord. 15 127-138.
164. G.D. Shelton, M. Ho and P.H. Kass (2000) Risk factors for acquired myasthenia gravis in cats: 105 cases (1986–1998). J. Am. Vet. Med. Assoc. 216 55-57.
165. G.D. Shelton, W.L. Nyhan, P.H. Kass, B.A. Barshop and R.H. Haas (1998) Analysis of organic acids, amino acids, and carnitine in dogs with lipid storage myopathy. Muscle Nerve 21 1202-1205.
166. G.D. Shelton and O. Paciello (2006) Evidence for MHC-1-restricted CD8+ T-cell-mediated immunopathology in canine masticatory muscle myositis and polymyositis. Muscle Nerve 34 122-123.
167. G.D. Shelton, M.D. Willard, G.H. Cardinet III. and J. Lindstrom (1990) Acquired myasthenia gravis. Selective involvement of esophageal, pharyngeal, and facial muscles. J. Vet. Intern. Med. 4 281-284.
168. J.P. Sieb and A.S. Penn (2004) Myoglobinuria. A.G. Engel, C. Franzini-Armstrong (Eds) Myology: Basic and Clinical New York: McGraw-Hill 1677-1692.
169. J.A. Slack, S.M. McGuirk, H.N. Erb, L. Lien, D. Coombs, S.D. Semrad, A. Riseberg, F. Marques, B. Darien, L. Fallon, P. Burns, M.A. Murakami, F.S. Apple and S.F. Peek (2005) Biochemical markers of cardiac injury in normal, surviving septic, or nonsurviving septic neonatal foals. J. Vet. Intern. Med. 19 577-580.
170. B.F. Smith, P.S. Henthorn, Y. Rajpurohit, H. Stedman, J.H. Wolfe, D.F. Patterson and U. Giger (1996) A cDNA encoding canine muscle-type phosphofructokinase. Gene 168 275-276.
171. D.H. Snow and S.J. Valberg (1994) Muscle-anatomy: adaptations to exercise and training. R.J. Rose, D.H. Hodgson (Eds) The Athletic Horse Philadelphia: Saunders 145-179.
172. S.J. Spier, G.P. Carlson, T.A. Holliday, G.H. Cardinet III. and J.G. Pickar (1990) Hyperkalemic periodic paralysis in horses. J. Am. Vet. Med. Assoc. 197 1009-1017.
173. L.L. Spriet (1991) Phosphofructokinase activity and acidosis during short-term tetanic contractions. Can. J. Physiol. Pharmacol. 69 298-304.
174. E. Steiness, F. Rasmussen, O. Svendsen and P. Nielsen (1978) A comparative study of serum creatine phosphokinase (CPK) activity in rabbits, pigs and humans after intramuscular injection of local damaging drugs. Acta Pharmacol. Toxicol. (Copenh.) 42 357-364.
175. M. Strbenc, V. Smerdu, M. Zupanc, N. Tozon and G. Fazarinc (2004) Pattern of myosin heavy chain isoforms in different fibre types of canine trunk and limb skeletal muscles. Cells Tissues Organs 176 178-186.
176. H.L. Sweeney and A. Houdusse (2004) Mammalian myosin. A.G. Engel, C. Franzini-Armstrong (Eds) Myology: Basic and Clinical New York: McGraw-Hill 167-186.
177. P. Tan, J.G. Allen, S.D. Wilton, P.A. Akkari, C.R. Huxtable and N.G. Laing (1997) A splice-site mutation causing ovine McArdle's disease. Neuromuscul. Disord. 7 336-342.
178. P.V. Tarrant and J.M. McVeigh (1979) The effect of skeletal muscle needle biopsy on blood constituents, muscle glycogen and heart rate of cattle. Res. Vet. Sci. 27 325-328.
179. A. Thorstensson, K. Elwin, B. Sjodin and J. Karlsson (1976) Isozymes of creatine phosphokinase and myokinase in human heart and skeletal muscle. Scand. J. Clin. Lab. Invest. 36 821-826.
180. S. Treves, A.A. Anderson, S. Ducreux, A. Divet, C. Bleunven, C. Grasso, S. Paesante and F. Zorzato (2005) Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders. Neuromuscul. Disord. 15 577-587.
181. S. Tsujino, I. Nonaka and S. DiMauro (2000) Glycogen storage myopathies. Neurol. Clin. 18 125-150.
182. P.C. Tullson and R.L. Terjung (1991) Adenine nucleotide metabolism in contracting skeletal muscle. Exerc. Sport Sci. Rev. 19 507-537.
183. S. Valberg (1986) Glycogen depletion patterns in the muscle of standardbred trotters after exercise of varying intensities and durations. Equine Vet. J. 18 479-484.
184. S. Valberg, J. Haggendal and A. Lindholm (1993) Blood chemistry and skeletal muscle metabolic responses to exercise in horses with recurrent exertional rhabdomyolysis. Equine Vet. J. 25 17-22.
185. S. Valberg, L. Jonsson, A. Lindholm and N. Holmgren (1993) Muscle histopathology and plasma aspartate aminotransferase, creatine kinase and myoglobin changes with exercise in horses with recurrent exertional rhabdomyolysis. Equine Vet. J. 25 11-16.
186. S.J. Valberg (1999) Spinal muscle pathology. Vet. Clin. North Am. Equine Pract. 15 vii-vii87.
187. S.J. Valberg, G.H. Cardinet III., G.P. Carlson and S. DiMauro (1992) Polysaccharide storage myopathy associated with recurrent exertional rhabdomyolysis in horses. Neuromuscul. Disord. 2 351-359.
188. S.J. Valberg, G.P. Carlson, G.H. Cardinet III., E.K. Birks, J.H. Jones, A. Chomyn and S. DiMauro (1994) Skeletal muscle mitochondrial myopathy as a cause of exercise intolerance in a horse. Muscle Nerve 17 305-312.
189. S.J. Valberg, J.R. Mickelson, E.M. Gallant, J.M. MacLeay, L. Lentz and F.D. de la Corte (1999) Exertional rhabdomyolysis in quarter horses and thoroughbreds: one syndrome, multiple aetiologies. Equine Vet. J. Suppl. 30 533-538.
190. S.J. Valberg, T.L. Ward, B. Rush, H. Kinde, H. Hiraragi, D. Nahey, J. Fyfe and J.R. Mickelson (2001) Glycogen branching enzyme deficiency in quarter horse foals. J. Vet. Intern. Med. 15 572-580.
191. C. Vijayasarathy, U. Giger, U. Prociuk, D.F. Patterson, E.B. Breitschwerdt and N.G. Avadhani (1994) Canine mitochondrial myopathy associated with reduced mitochondrial mRNA and altered cytochrome c oxidase activities in fibroblasts and skeletal muscle. Comp. Biochem. Physiol. A Physiol. 109 887-894.
192. C.H. Vite, F. Cozzi, M. Rich, A.K. Klide, S.W. Volk and R. Lombardo (1998) Myotonic myopathy in a miniature schnauzer: case report and data suggesting abnormal chloride conductance across the muscle membrane. J. Vet. Intern. Med. 12 394-397.
193. L. Volfinger, V. Lassourd, J.M. Michaux, J.P. Braun and P.L. Toutain (1994) Kinetic evaluation of muscle damage during exercise by calculation of amount of creatine kinase released. Am. J. Physiol. 266(pt. 2), R434-rR441.
194. M.L. Wagner, S.J. Valberg, E.G. Ames, M.M. Bauer, J.A. Wiseman, M.C.T. Penedo, H. Kinde, B. Abbitt and J.R. Mickelson (2006) Allele frequency and likely impact of the glycogen branching enzyme deficiency gene in quarter horse and paint horse populations. J. Vet. Intern. Med. 20 1207-1211.
195. J. Wahren (1977) Glucose turnover during exercise in man. Ann. NY Acad. Sci. 301 45-55.
196. H.C. Walvoort, R.G. Slee and J.F. Koster (1982) Canine glycogen storage disease type II. A biochemical study of an acid alpha-glucosidase-deficient Lapland dog. Biochim. Biophys. Acta 715 63-69.
197. K. Wang and R. Ramirez-Mitchell (1983) A network of transverse and longitudinal intermediate filaments is associated with sarcomeres of adult vertebrate skeletal muscle. J. Cell Biol. 96 562-570.
198. T.L. Ward, S.J. Valberg, D.L. Adelson, C.A. Abbey, M.M. Binns and J.R. Mickelson (2004) Glycogen branching enzyme (GBE1) mutation causing equine glycogen storage disease IV. Mamm. Genome 15 570-577.
199. A.G. Weeds (1969) Light chains of myosin. Nature 223 1362-1364.
200. S. Yamano, D. Eto, Y. Kasashima, A. Hiraga, T. Sugiura and H. Miyata (2005) Evaluation of developmental changes in the coexpression of myosin heavy chains and metabolic properties of equine skeletal muscle fibers. Am. J. Vet. Res. 66 401-405.
201. J. Zhou, S.J. Spier, J. Beech and E.P. Hoffman (1994) Pathophysiology of sodium channelopathies: correlation of normal/mutant mRNA ratios with clinical phenotype in dominantly inherited periodic paralysis. Hum. Mol. Genet. 3 1599-1603.